 Money News 10 and 40 past the hour as we go to Andrew O'Day. This is a Bloomberg Money Minute. The U.S. government will pay COVID vaccine maker Moderna nearly $200 million to accelerate development of a vaccine for flus, including the dangerous strain of bird flu currently sweeping through the nation's dairy farms. The mRNA vaccine will be tailored so it can target several flu strains that carry pandemic potential. Results from Moderna's early studies of the bird flu shot are expected in the next few weeks.